throbber
Paper No. 30
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`------------------
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`------------------
`
`ABS GLOBAL, INC.,
`Petitioner,
`
`v.
`
`CYTONOME/ST, LLC,
`Patent Owner.
`
`------------------
`Case No. IPR2017-02097
`Patent No. 8,529,161 B2
`------------------
`
`PETITIONER'S REPLY
`
`

`

`IPR2017-02097
`
`Petitioner's Reply
`
`TABLE OF CONTENTS
`
`I.
`II.
`
`Introduction ...................................................................................................... 1
`Claim Construction .......................................................................................... 3
`A.
`"Adjusting" ............................................................................................ 3
`B.
`"Focusing" (Claims 6, 7, 14, 15) ........................................................... 7
`i.
`Focusing Does Not Require "Accelerating Sheath Fluid" .......... 8
`ii.
`Focusing Does Not Require "Aligning the Particle Stream" .... 13
`"Orienting" (claims 8 and 16) ............................................................. 14
`C.
`III. Claims 1-20 Are Anticipated by Wada ......................................................... 15
`A. Wada Describes Adjusting (Claims 1 and 9) ...................................... 15
`B. Wada Describes Focusing (Claims 6-7, 14-15) .................................. 16
`C. Wada Describes Orienting (Claims 8, 16) .......................................... 23
`D. Wada Describes Positioning One or More Particles
`(Claims 18, 20) .................................................................................... 24
`E. Wada Describes a Sample Inlet (Claims 17, 19) ................................ 24
`F. Wada Describes the Remaining Dependent Limitations .................... 25
`IV. Claims 1 to 20 Would Have Been Obvious ................................................... 25
`V.
`Conclusion ..................................................................................................... 27
`
`
`
`
`
`
`i
`
`

`

`IPR2017-02097
`
`Petitioner's Reply
`
`TABLE OF AUTHORITIES
`
` Page(s)
`
`Cases
`Aspex Eyewear, Inc. v. Marchon Eyewear, Inc.,
`672 F.3d 1335 (Fed. Cir. 2012) .......................................................................... 13
`Brown v. 3M,
`265 F.3d 1349 (Fed. Cir. 2001) ............................................................................ 3
`Hewlett-Packard Co. v. Bausch & Lomb Inc.,
`909 F.2d 1464 (Fed. Cir. 1990) .......................................................................... 18
`Luminara Worldwide v. Liown Elecs. Co.,
`814 F.3d 1343 (Fed. Cir. 2016) .......................................................................... 12
`Rambus Inc. v. Infineon Techs. AG,
`318 F.3d 1081 (Fed. Cir. 2003) .......................................................................... 12
`TriVascular, Inc. v. Samuels,
`812 F.3d 1056 (Fed. Cir. 2016) ............................................................................ 7
`
`
`
`
`ii
`
`

`

`IPR2017-02097
`
`I.
`
`Introduction
`
`Petitioner's Reply
`
`The Board correctly found that Wada anticipates claims 1, 4, 8, 9, 12 and 16
`
`to 20 because Wada describes a microfluidic system comprising a primary flow
`
`channel and at least two regions in which hydrodynamic flows adjust a sample.
`
`Paper 11 ("Dec."), 21-25. The Board, however, initially found claims 2-3, 5-7, 10-
`
`11 and 13-15 not anticipated by Wada based largely on erroneous testimony from
`
`Patent Owner's expert, finding these claims to have added requirements putatively
`
`not described in Wada. Patent Owner's Response disputes the Board's findings of
`
`anticipation, and seeks to extend the Board's findings regarding claims 2-3, 5-7,
`
`10-11 and 13-15. Throughout, Patent Owner strains to read new requirements into
`
`the claims and distorts Wada.
`
`For claims the Board found anticipated, Patent Owner attempts to add
`
`requirements found nowhere in the claims. For example, it asserts that the claims
`
`require adjustments to an intact "suspended core sample" comprised of some
`
`undefined multiplicity of particles. But that conflicts with the literal claim
`
`language specifying that a sample can contain a single particle ("a sample having
`
`one or more particles") and that adjustments can be made to "one or more particles
`
`in the sample."
`
`The Board's initial findings of no anticipation of claims 2-3, 5-7, 10-11 and
`
`13-15 contain similar errors. Most notably, the Board misread the claims to require
`
`1
`
`

`

`IPR2017-02097
`
`Petitioner's Reply
`
`the "secondary adjustment" to occur before detection or sorting of particles. Dec.,
`
`26. There is no such requirement in the claims. This error was compounded by
`
`Patent Owner's and its expert's unsupported assertions that "focusing" does not
`
`occur in the second region of Wada's device in Figure 23 because the "purpose" of
`
`that region was to "direct" a particle to one of two final destinations. But Wada
`
`describes using the same microfluidic techniques in both regions, and the Board
`
`found the first region performs "focusing." It thus cannot be correct that "focusing"
`
`occurs in the first but not the second region of Wada's system.
`
`The Board also misapprehended Petitioner's obviousness grounds, which
`
`explained, by reliance on Micronics 2001, that a skilled person, when
`
`implementing a microfluidic system, engages in an iterative process that involves
`
`adapting the physical structure of a microfluidic system to yield a desired flow
`
`pattern. Because the claims are directed to the use of conventional microfluidic
`
`structures to achieve an entirely functional outcome, Petitioner presented
`
`Micronics 2001 to foreclose the possibility that Patent Owner would contend some
`
`unspecified configuration of the claimed system would render them patentable.
`
`The skilled person would have found each claim obvious because each simply
`
`specifies the predictable result of well-known configurations to the physical
`
`structure of microfluidic systems. Di Carlo ¶¶92-94.
`
`2
`
`

`

`IPR2017-02097
`
`Petitioner's Reply
`
`Patent Owner's arguments all ultimately rest on illusory distinctions that
`
`require the Board to adopt strained clam interpretations that conflict with the
`
`claims and disclosure, and with admissions from named '161 patent inventors.
`
`Each claim should be held unpatentable over Wada alone or with Micronics 2001.
`
`II. Claim Construction
`The claim construction disputes concern "adjusting," "focusing," and
`
`"orienting" a "sample." Patent Owner's assertions on each must be rejected as
`
`inconsistent with the claims and the plain meaning of each term.
`
`"Adjusting"
`
`A.
`The patent uses "adjust" with its plain and ordinary meaning, which the
`
`Board correctly found is "to move." Dec., 8. Nothing in the specification suggests
`
`otherwise. See Brown v. 3M, 265 F.3d 1349, 1352 (Fed. Cir. 2001) (affirming plain
`
`meaning for claim limitations that "are not technical terms of art, and do not
`
`require elaborate interpretation"). Nevertheless, Patent Owner presents two
`
`alternative constructions for "adjusting" that improperly import numerous
`
`limitations.
`
`Patent Owner first contends that "in addition to 'moving,'" "adjusting"
`
`requires "at least preserv[ing] (i.e., not disrupt[ing]) the suspended sample core."
`
`Paper 25 ("POR"), 28-29. But this construction contradicts the claims, which
`
`nowhere refer to a "suspended sample core" and consistently state that only a
`
`3
`
`

`

`IPR2017-02097
`
`Petitioner's Reply
`
`single particle need be the object of an "adjustment." For example, claims 1 and 9
`
`require "flowing a sample having one or more particles," which expressly
`
`includes adjustments to a sample having a single particle. Ex. 1031 ("Di Carlo")
`
`¶53.
`
`The dependent claims also make clear that the object of an "adjustment" can
`
`be a single particle. See, e.g., claim 3 ("…aligning the sample includes aligning
`
`one or more particles in the sample"); claim 4 ("…adjusting the sample…includes
`
`adjusting a spatial characteristic of one or more particles in the sample."); claim
`
`10 ("…aligning the sample includes aligning one or more particles in the
`
`sample"); Claim 11 ("…adjusting the sample…includes adjusting a spatial
`
`characteristic of one or more particles in the sample."). The claim language thus
`
`rules out Patent Owner's assertion that the claims require adjustments to be made to
`
`some unspecified multiplicity of particles that are spatially positioned in some
`
`manner in a sample (i.e., within a "sample core").1
`
`
`
`1
`
`Patent Owner's proposed "suspended sample core" requirement cannot be
`
`reconciled with the skilled person's understanding that when a samples contains a
`
`multiplicity of particles, the particles are randomly dispersed in the suspension
`
`medium. See Ex. 1003 ¶128.
`
`4
`
`

`

`IPR2017-02097
`
`Petitioner's Reply
`
`Patent Owner's alternative theory is that "adjusting" means moving "into
`
`proper position for use." POR, 29. But none of the claims require a sample to be
`
`positioned in any particular manner. The two dependent claims that mention
`
`"positioning" allow the sample to be positioned anywhere "within the primary flow
`
`channel." Ex. 1001, cls. 18, 20. The specification likewise allows that the sample
`
`"may or may not be at center of the primary sheath flow channel…." Id., 7:60-62,
`
`8:1-2. It also makes clear that the sample may be passed to any "component in
`
`fluid communication with an outlet," not just one with a detector or sensor as
`
`Patent Owner suggests. Id., 5:15-18, 1:48-50. There is thus no basis for importing
`
`positioning requirements into the claims, POR, 29, including that the sample be
`
`positioned "in-line with a detector or sensor for a microfluidic system."
`
`The claims also do not require a subjectively "desirable change" in the
`
`sample size or shape to form a "narrow sample core" (POR, 29) and the
`
`specification provides no objective basis for gauging such a limitation.2 Indeed,
`
`incorporating such a meaning into the claims would render them indefinite, as each
`
`"proper position for use" would depend on the configuration of each system being
`
`used. See, e.g., Ex. 1001, 7:6-7, 5:46-48, 7:14-15, 8:15-16, 7:34-37 (allowing
`
`
`
`2
`
`Although a sample width is reported in the specification ('161 patent at
`
`10:27-29), no range is provided, nor are any metrics for sample height or shape.
`
`5
`
`

`

`IPR2017-02097
`
`Petitioner's Reply
`
`introduction of sheath fluid from any suitable direction, inlets in any suitable
`
`location, and channels shaped in any suitable manner).
`
`The Board also correctly rejected Patent Owner's assertion that the "sample
`
`as a whole must be adjusted in all claims" because it is "not entirely clear." Dec., 7.
`
`Dr. Kapur's testimony that "a 'sample' remains a single sample even if portions of
`
`the sample have been split into separate flows or into separate channel [sic]"
`
`simply perpetuates this confusion. Ex. 2005 ¶11. Critically, the claims require only
`
`a single particle to be adjusted. Di Carlo ¶¶53-54.
`
`Other theories advanced by Patent Owner's expert are likewise contrary to
`
`the claim language and the intrinsic evidence. For example, Dr. Kapur suggests
`
`that "adjusting" does not require moving the sample at all, stating that "the
`
`percentage of sample fluid relative to sheath fluid could be 'adjusted' by reducing
`
`the percentage of sample fluid." Ex. 2005 ¶12. But the claims make clear that
`
`"introducing additional suspension medium into the primary flow channel" adjusts
`
`the sample direction, not its percentage. Di Carlo ¶55.
`
`The Board should therefore maintain its construction of "adjust" as having
`
`its plain and ordinary meaning of "move."3
`
`
`
`3 While Patent Owner complains this dictionary definition was "cherry-picked," a
`
`review of the other definitions shows they are irrelevant, and concern unrelated
`
`6
`
`

`

`IPR2017-02097
`
`Petitioner's Reply
`
`"Focusing" (Claims 6, 7, 14, 15)
`
`B.
`As the Board recognized, a "focused particle stream" was well-understood in
`
`the art to mean "a particle stream that is substantially focused, pinched, narrowed,
`
`or otherwise confined…." Dec., 15 (quoting Wada, 8:22-25, 10:26-29). The same
`
`focusing language is found in the specification. Ex. 1001, 1:32-34 ("pinch"), 1:34-
`
`36 ("narrowed"), 2:9-11 ("confined"). To the extent a construction of "focusing" is
`
`needed, this plain and ordinary meaning—"pinching, narrowing, or otherwise
`
`confined"—is appropriate.
`
`At Patent Owner's urging, the Board included two additional requirements
`
`for "focusing": (i) use of an "accelerating sheath fluid to exert a force on the
`
`particles" and (ii) "aligning the particle stream." Neither limitation comports with
`
`the claim language or the plain meaning of "focusing" as it is used in the
`
`disclosure.4 TriVascular, Inc. v. Samuels, 812 F.3d 1056, 1068 (Fed. Cir. 2016); Di
`
`Carlo ¶14-51.
`
`
`
`contexts (e.g., adjusting expenses, insurance, and environmental adaptation). See
`
`Ex. 1009 at 25.
`
`4
`
`The Board's preliminary construction also requires that "focusing" occur "in
`
`a desired direction relative to the boundaries of the channel" and "while achieving
`
`or maintaining laminar flow." The claims, however, separately specify that
`
`7
`
`

`

`IPR2017-02097
`
`Petitioner's Reply
`
`i. Focusing Does Not Require "Accelerating Sheath Fluid"
`
`A skilled person reading the '161 patent would not have concluded that
`
`"focusing" requires "accelerating sheath fluid to exert a force on the particles. "
`
`Nothing in the patent disclosure compels that conclusion, and two named inventors
`
`testified that "focusing" as used in the '161 patent and understood in the field does
`
`not require an accelerating sheath fluid.5 Di Carlo ¶¶ 14-48.
`
`First, Dr. John Gilbert, a named inventor and the founder of Cytonome,
`
`testified that "focusing"—both with its ordinary meaning and as it is used in his
`
`patents—does not require an accelerating sheath fluid:
`
`Q. Does the term "focusing," as you use it in your patent, require
`accelerating the sheath fluid?
`A.
`So - no, it doesn't require it. It might happen anyway, but it's
`not required.
`
`
`
`focusing occurs in at least two different directions, such that additional recitation
`
`of the direction would be superfluous. And flow is laminar in microfluidic devices
`
`regardless of whether focusing occurs. Di Carlo ¶¶85-86, 89.
`
`5
`
`The testimony of these two inventors is probative because it reflects
`
`contemporaneous views of those working in the field of the patent on the plain and
`
`ordinary meaning of "focusing" and confirms that "focusing" as used in the '161
`
`patent did not have a special definition at odds with its plain meaning.
`
`8
`
`

`

`IPR2017-02097
`
`Petitioner's Reply
`
`…
`Just in terms of your own personal experience at the time you
`Q.
`filed your patent application, was it understood in the field at the time
`that focusing required accelerating the sheath fluid?
`A.
`So I don't believe people would even agree that that was true.
`
`Ex. 1026, Gilbert Tr., 229:43-8, 229:25-230:6; see also id., 47:3-5; Di Carlo ¶41-
`
`42.
`
`Dr. Bernard Bunner, another named inventor, likewise testified that sheath
`
`fluid "acceleration" occurs only in a tapered primary focusing region and only in a
`
`horizontal dimension:
`
`Q. So in your devices, the only acceleration is going to be in the
`horizontal dimension and in the area where the device tapers the flow
`channel; right?
`A. Yes.
`
`Ex. 1027, Bunner Tr., 151:7-152:5; Di Carlo ¶43.
`
`The inventors' testimony reflects how microfluidic systems function. In
`
`them, sheath fluid is conventionally injected into the primary flow channel at a
`
`higher flow rate than the sample fluid. Di Carlo ¶38 (citing sheath-to-sample flow-
`
`9
`
`

`

`IPR2017-02097
`
`Petitioner's Reply
`
`rate ratios ranging from 2.5:1 to 120:1).6 This produces a "difference in velocity"
`
`between the sheath and sample fluids that causes the sample fluid to be narrowed,
`
`pinched, or otherwise confined by the sheath fluid. Sheath fluid itself does not need
`
`to be "accelerating" in a particular region to exert a force on particles in a sample
`
`because it is already moving at a higher rate than the sample fluid layer. Di Carlo
`
`¶38. Consequently, as Patent Owner's expert acknowledged, "focusing" can be
`
`achieved with a "difference in fluid velocity between sheath fluid and sample
`
`fluid" and thus does not require an "accelerating sheath fluid." Ex. 2002 ¶12.
`
`The specification likewise makes clear that an "accelerating" sheath fluid is
`
`not required for "focusing." Notably, the specification explains that the primary
`
`focusing region may be configured in a manner that preferably "accelerates and
`
`focuses the sheath fluid" (Ex. 1001, 4:63-65 (emphasis added)), whereas the
`
`secondary focusing region simply focuses (see, e.g., id., 2:12-17, 6:17-31). Pet. 25.
`
`This distinction recurs throughout the specification, where several examples reflect
`
`no "acceleration" even in the primary focusing region. See, e.g., id., 8:21-26, 2:6-
`
`12, 2:36-41, 3:22-27, 4:63-5:6; Di Carlo ¶¶39-40.
`
`
`
`6
`
`The '161 patent itself recites a flow-rate ratio of "45:1," such that prior to
`
`entering the focusing regions, the sheath fluid flows at a rate 45 times greater than
`
`the sample fluid. '161 patent at 9:46-47; Di Carlo ¶38
`
`10
`
`

`

`IPR2017-02097
`
`Petitioner's Reply
`
`Dr. Bunner's testimony reinforces this point, as he testified that some
`
`focusing regions in his alleged invention may both accelerate and focus, but others
`
`only focus:
`
`Q. So, in your view, the primary focusing region includes accelerating
`and focusing steps; right?
`[Attorney Objections]
`A. Yes.
`Q. Now, in the second focusing region, is there both accelerating and
`focusing in the secondary focusing region as well?
`A. No.
`Q. So some regions have [acceleration] and some regions don't in your
`devices; right?
`A. The primary focusing region has -- the primary focusing region
`uses accelerating of the flow, for horizontal focusing.
`Q. And the secondary focusing reason does not use accelerating;
`right?
`A. No.
`Q. Okay. And that's your understanding of how your devices work;
`right?
`A. Yes.
`
`Ex. 1027, 377:14-378:12; Di Carlo ¶ 44.
`
`The specification in conjunction with this testimony makes clear that the
`
`inventors did not act as their own lexicographer – they did not "clearly set forth a
`
`definition" of "focusing" or "clearly express an intent to redefine the term."
`
`11
`
`

`

`IPR2017-02097
`
`Petitioner's Reply
`
`Luminara Worldwide v. Liown Elecs. Co., 814 F.3d 1343, 1353 (Fed. Cir. 2016);
`
`Di Carlo ¶45.
`
`Patent Owner also never made a "clear and unmistakable disavowal" of
`
`claim scope to exclude focusing that occurs without accelerating sheath fluid. Id.
`
`Indeed, a skilled person would have regarded the prosecution argument Patent
`
`Owner relies on – that "focusing requires acceleration and removal of sheath fluid
`
`from around a particle" – as facially inaccurate. See Rambus Inc. v. Infineon Techs.
`
`AG, 318 F.3d 1081, 1090 (Fed. Cir. 2003) (an "incorrect statement in the
`
`prosecution history does not govern the meaning of the claims"; the "claim
`
`language itself controls the bounds of the claim, not a facially inaccurate remark
`
`during prosecution"); Di Carlo ¶46. Ohki discloses "focusing" even under Patent
`
`Owner's construction of the term. Di Carlo ¶¶20-35, 47-48. And as to whether
`
`focusing requires "removal of sheath fluid," Dr. Gilbert testified unequivocally:
`
`"[I]t doesn't require it" and "we don't teach removal of sheath fluid in this patent."
`
`Ex. 1026, 234:6-9, 234:24-235:3.
`
`Importantly, Patent Owner did not distinguish the claims over the examiner's
`
`asserted prior art reference (Ex. 3001, "Ohki") by relying on the construction for
`
`"focusing" it now advances. Dec., 16-17. Patent Owner could not contend that the
`
`Ohki devices do not "focus" a sample. Di Carlo ¶¶20-35. The field had
`
`acknowledged that these devices produce "sample sheathing and hydrodynamic
`
`12
`
`

`

`IPR2017-02097
`
`Petitioner's Reply
`
`focusing on all four sides." Di Carlo ¶33 (quoting Ex. 1028, 236). Patent Owner
`
`distinguished Ohki as showing only one focusing region. Ex. 2001, 49.
`
`The intrinsic and extrinsic evidence thus demonstrate "focusing" does not
`
`require "accelerating sheath fluid."
`
`ii. Focusing Does Not Require "Aligning the Particle Stream"
`
`The Board's conclusion that "focusing" requires "aligning the particle
`
`stream" is similarly inconsistent with the claims and inventor testimony.
`
`Dependent claims 2, 3, 10 and 11 make clear that "aligning" a sample is
`
`distinct from "focusing" a sample. See, e.g., claim 2, ("wherein adjusting the
`
`sample … includes aligning the sample."). "[W]hen different words are used in
`
`separate claims, they are presumed to have different meanings." Aspex Eyewear,
`
`Inc. v. Marchon Eyewear, Inc., 672 F.3d 1335, 1349 (Fed. Cir. 2012).
`
`The Board also did not have the benefit of inventor testimony when it found
`
`"focusing" to require "aligning the particle stream." Dr. Gilbert testified that
`
`focusing may result in aligning the particle stream if the particle-stream diameter is
`
`narrowed to "approach the diameter…of the particles," but that otherwise the
`
`particle stream will be distributed across the sample stream. Ex. 1026, 233:15-
`
`234:5. Thus, "aligning" a sample is not a necessary feature of "focusing" a sample
`
`according to the patent. Di Carlo ¶¶49-51.
`
`13
`
`

`

`IPR2017-02097
`
`Petitioner's Reply
`
`"Orienting" (claims 8 and 16)
`
`C.
`Claims 8 and 16 specify that "adjusting" a sample includes "orienting" it. In
`
`its preliminary response, Patent Owner did not dispute that "orienting the sample"
`
`means "moving the…sample into a specified position." Paper 9, 30; Dec., 30-31.
`
`Patent Owner has now changed course and contends that "orienting the sample"
`
`requires "providing directionality to asymmetric particles within a sample," that
`
`such directionality must be provided "in the entire sample," and that all particles
`
`have the same directionality. POR, 37-38.
`
`Patent Owner's proposed construction should be rejected because it conflicts
`
`with the claims and requires reading unsupported requirements into the claims.
`
`First, as explained above, the claims state that a sample can contain a single
`
`particle. Requiring a multiplicity of particles in the sample contradicts the claims.
`
`Second, no claim requires a sample to contain "asymmetric" particles; the
`
`only example of a "sample having one or more particles" in the specification
`
`contains symmetric, spherical particles. Ex. 1001, 9:44-46 (specifying "6 micron
`
`yellow beads from Spherotech"); Di Carlo ¶58-59. As Dr. Di Carlo testified,
`
`"particles that are spherical have no directionality." Ex. 2004, 75:25-76:1. There is
`
`thus no basis for limiting a "sample" to a multiplicity of "asymmetric particles."
`
`Finally, Patent Owner's expert's testimony on this term relies on a mistaken
`
`reading of the claims and should be disregarded. Di Carlo ¶¶56-57. Dr. Kapur
`
`14
`
`

`

`IPR2017-02097
`
`Petitioner's Reply
`
`apparently understood the term "orienting the sample" to mean that "the entire
`
`sample directionally orients asymmetrical particles." Ex. 2005 ¶13. But the claim
`
`clearly states that "introducing additional suspension medium" orients the particles,
`
`not that the sample itself orients the particles.
`
`The Board's preliminary construction of the "orienting" was therefore correct
`
`and should be maintained. Di Carlo ¶60.
`
`III. Claims 1-20 Are Anticipated by Wada
`A. Wada Describes Adjusting (Claims 1 and 9)
`The Board correctly found claims 1 and 9 anticipated. Dec., 22-25. Wada
`
`describes microfluidic systems in which a sample comprising at least one particle
`
`is moved in a first direction in a first hydrodynamic focusing region and then is
`
`moved in a different direction in a second hydrodynamic focusing region. Pet., 35-
`
`55; see, e.g., Wada, 9:8-26, 11:34-12:37, 13:1-33, 23:18-24, Figs. 1, 22-23; see
`
`also id., cl. 6. Nothing more is required by the claims, which compels a finding of
`
`anticipation.
`
`Patent Owner's response relies entirely on its implausible alternative claim
`
`constructions, all of which should be rejected. See supra Section II. Patent Owner
`
`also mischaracterizes what Wada actually shows, contending that the offset
`
`focusing microchannels in Wada Figure 23 split the sample into separate flows or
`
`into separate channels. That is incorrect. Wada describes adjusting a sample stream
`
`15
`
`

`

`IPR2017-02097
`
`Petitioner's Reply
`
`containing one or more particles first to the left and then to the right using distinct
`
`hydrodynamic focusing regions. As explained in the Petition, this two-step
`
`focusing process directs a sample containing selected particles—still surrounded
`
`by sheath fluid—into the right-hand collection channel. Pet., 66. The entirety of
`
`that sample containing those particles at each adjustment region is thus adjusted in
`
`the specified direction, exactly as the claims specify. Di Carlo ¶¶62-68.
`
`B. Wada Describes Focusing (Claims 6-7, 14-15)
`Based on Patent Owner's assertions about how the second adjustment region
`
`in Wada Figure 23 functions, the Board concluded that the Wada Figure 23 device
`
`does not anticipate claims 6, 7, 14 and 15. That conclusion cannot be reconciled
`
`with the claim language or Wada's descriptions.
`
`Initially, the Board found that the first region in Wada Figure 23 performs
`
`"focusing," even under its preliminary construction. Dec., 26 ("Thus, Wada
`
`describes that focusing occurs in Petitioner's blue shaded region…"). The Board
`
`also acknowledged that "…Wada discloses the aspects of horizontal and vertical
`
`focusing and different flow structure embodiments, which may focus a sample
`
`within a flow channel." Dec., 27 (citing Pet. 63 (citing Ex. 1006, 9:8-22, 9:60-10:4,
`
`Fig. 1A, Figs. 21-23)).
`
`The Board, however, found that the second region (in green) in Wada Figure
`
`23 does not perform focusing. Dec., 26. It did so by crediting Patent Owner's
`
`16
`
`

`

`IPR2017-02097
`
`Petitioner's Reply
`
`assertions that because this second region "is for
`
`sorting, not focusing" it does not perform
`
`"focusing." Dec., 24-25. The Board also cited
`
`Patent Owner's expert testimony that the "sorting
`
`Wada teaches in Petitioner's green shaded region
`
`of Figure 23 does not constitute focusing because
`
`it does not narrow and align the particle stream
`
`within a laminar flow" and his assertions that particles in the Wada device are
`
`forced "out of focused laminar flow … and causes the sheath and sample fluids to
`
`mix." Dec., 26-27 (citing Ex. 2002 ¶14).
`
`Patent Owner's and its expert's assertions about how the Wada systems
`
`function are simply incorrect, which led the Board to incorrectly conclude that the
`
`second region in Figure 23 does not focus. Di Carlo ¶¶69-71. Critically, the
`
`Board's conclusion that the first region (blue) in Wada's Figure 23 device performs
`
`"focusing" compels the conclusion that the second region (green) does, too. That is
`
`because the two regions have the same structure and function in the identical
`
`manner – each uses the same offset microchannel design to introduce a sheath flow
`
`17
`
`

`

`IPR2017-02097
`
`Petitioner's Reply
`
`into the primary flow channel that moves one or more particles within a sample in
`
`a different direction.7 Di Carlo ¶¶72-76; Wada, 13:17-33.
`
`More specifically, Wada applies the same "hydrodynamic flow 2302" to the
`
`selected particles (represented by black circles) through each focusing
`
`microchannel in the series. E.g., Pet., 50-55, 62-65. The second focusing
`
`microchannel is the same size, shape and proportion, and is depicted in Figure 23
`
`as introducing the same "hydrodynamic flow 2302" to force particles away from
`
`the primary flow channel walls as the first focusing microchannel. Wada, 13:17-
`
`33, Fig. 23; see also Wada, 11:34-13:33 (describing "Use of Focusing to Sort
`
`Particles"); Di Carlo ¶¶77-81; Ex. 2004, 54:23-64:21, 71:7-20. By doing so, each
`
`region necessarily causes a narrowing and alignment of the particle stream in a
`
`particular direction, and each creates a laminar flow wherein the introduced sheath
`
`fluid surrounds the fluid layer containing the particles. Di Carlo ¶¶82-89; Wada,
`
`11:34-13:33, 23:19-24. Thus, as Wada itself states, its system uses "a series of
`
`offset focusing microchannels to achieve focusing by serial introduction of fluids
`
`
`
`7
`
`See Hewlett-Packard Co. v. Bausch & Lomb Inc., 909 F.2d 1464, 1469 (Fed.
`
`Cir. 1990) ("[A]pparatus claims cover what a device is, not what a device does.")
`
`(original emphasis).
`
`18
`
`

`

`IPR2017-02097
`
`Petitioner's Reply
`
`from the offset channels." Pet., 38-39, 46-47 (quoting Wada, 9:13-17) (emphasis
`
`added).
`
`Patent Owner's expert also incorrectly portrayed how Wada's Figure 23
`
`device functions, asserting, inter alia, that it mixes the sample and sheath flows
`
`within the green-shaded region of Figure 23. See Ex. 2002 ¶¶14-16; Ex. 2005
`
`¶¶14-16. That is incorrect – the two flows only mix when combined further
`
`downstream in the collection wells (2312) not upstream at the claimed secondary
`
`adjustment region where laminar flow is maintained. Di Carlo ¶73. Moreover, as
`
`Figure 23 itself illustrates, the secondary focusing region focuses the entire
`
`selected particle stream toward the right side of the primary flow channel so that
`
`particles in the stream flow through the desired collection channel and into the
`
`collection well. Di Carlo ¶77.
`
`The second, green-shaded region of Figure 23 also narrows and aligns the
`
`particle stream within a laminar flow – that is the necessary consequence of the
`
`introduction of sheath fluid in the identical manner as in the first focusing region,
`
`which the Board found meets the "focusing" requirement. Indeed, the only
`
`difference between the two regions is the direction in which the hydrodynamic
`
`focusing flows are introduced into the primary flow channel, as required by the
`
`contested claims. Both focusing microchannels thus apply hydrodynamic flows
`
`that meet the Board's interpretation of "focusing" of a sample containing one or
`
`19
`
`

`

`IPR2017-02097
`
`Petitioner's Reply
`
`more particles, as well as the plain and ordinary meaning of "focusing." Di Carlo
`
`¶¶81-90.
`
`Wada's use of the word "direct" rather than "focusing" to describe the
`
`purpose of the focusing in the second region (Wada, 13:21-31) may have led the
`
`Board to improperly credit Patent Owner's argument that Wada's second focusing
`
`microchannel does not perform "focusing" when used to process a sample
`
`containing some "selected" and some "unselected" particles. The defect in Patent
`
`Owner's position, however, is shown by a single example: when used to process a
`
`sample containing only one or more "selected" particles, the device described in
`
`Figure 23 continuously focuses the entire sample into the right-hand collection
`
`channel. Ex. 2004, Di Carlo Tr., 72:19-73:4; Di Carlo ¶68.
`
`Regardless, as the figures in Wada identified in the Petition show,
`
`"directing" is the result of "focusing," not a different phenomenon. Di Carlo ¶¶ 74-
`
`77. For example, Wada describes Figure 22—identified in the Petition as another
`
`example of "a series of offset focusing channels" (Pet. 39-40)—employs "at least
`
`two sets of opposing microchannels for focusing and/or otherwise directing the
`
`flow of cells." Wada, 13:2-5 (emphasis added); see also id., 7:30-33 ("Fig. 22 is a
`
`schematic illustration of a particle sorting configuration utilizing sets of opposing
`
`microchannels to focus and/or otherwise direct the flow of the members of, e.g., a
`
`cell population to achieve cell sorting.").
`
`20
`
`

`

`IPR2017-02097
`
`Petitioner's Reply
`
`The prosecution history and issued claims of Wada reinforce that Wada uses
`
`"focusing" to "direct" a sample and the particles in it. Di Carlo ¶¶78-80. For
`
`example, the Wada applicants cited Figure 23 and its description as providing
`
`"ample support" for claims in which "directing" is the consequence "focusing"
`
`applied by the hydrodynamic flows shown in the figure. See Ex. 1018, 142-43.
`
`Claim 6 of Wada likewise recites "focusing the particles" in a first region "such
`
`that the particles are directed toward a first side of at least opposing first and
`
`se

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket